While E-cadherin downregulation promotes epithelial-mesenchymal transition (EMT), a key process in cancer metastasis, P-cadherin overexpression in PDAC may exacerbate this effect, leading to increased tumor invasiveness. Here, CDH1 is linked to cancer.